Risk/Benefit “Fair Balance” In DTC Ads Leads To Confusion – Petition

FDA should redefine its policy of requiring "fair balance" of risk and benefit information in prescription drug advertising, the Coalition for Healthcare Communication says in a March 31 citizen petition

More from Archive

More from Pink Sheet